Do you have the same question? Follow this Question
May 22, 2025 - 09:48 AM
We’ve provided several answers to questions related to Atelvia (Risedronate) Delayed Release , see some other helpful Q&A related to this product.
Question: What should be done if a person experiences severe pain in bones, joints, or muscles while taking this medication?
Answer: If severe pain in bones, joints, or muscles occurs, stop taking the medication and contact your doctor immediately. Prompt response to these symptoms can prevent more serious complications and ensure timely intervention.
Question: What is the PubChem CID for Risedronate Sodium?
Answer: The PubChem CID is 224004. This identifier is useful for researchers and healthcare providers to access detailed chemical information about the drug.
Question: What is the ATC code for this medication?
Answer: The ATC code for this medication is M05BA07. The Anatomical Therapeutic Chemical (ATC) classification system helps healthcare providers and pharmacists identify drugs and understand their therapeutic purposes.
Question: What is the bioavailability of this medication when taken orally while fasting?
Answer: The bioavailability is approximately 0.63% when taken orally in a fasting state. This low bioavailability is typical for bisphosphonates, and the specific instructions for taking the medication aim to maximize absorption.
Question: What is the legal status of this medication?
Answer: This medication is prescription only (Rx), meaning it requires a doctor's prescription to obtain. This ensures that it is used safely and appropriately under medical supervision.
View all Atelvia (Risedronate) Delayed Release Questions & Answers
